Dermatology

The Biology of GPP and Look-Alike Conditions

At a Glance

Generalized pustular psoriasis is linked to an overactive immune alarm called IL-36, sometimes influenced by gene changes. Specialists may use medication history, cultures, clinical findings, and a biopsy to distinguish GPP from similar conditions.

Generalized Pustular Psoriasis (GPP) is more than just a skin condition; it is a complex breakdown in the way your body’s immune system communicates. While it can look like other diseases, its underlying biology and genetic drivers make it a unique medical challenge.

The IL-36 Pathway: An Overactive Alarm

The primary driver of GPP is a specific signaling pathway in your immune system called the IL-36 pathway ^[1]. Think of this pathway like a smoke alarm for your skin. In a healthy person, the body releases “alarms” (called IL-36 agonists) to trigger inflammation when there is a threat, like an infection. To keep this in check, the body also produces a “silencer” (the IL-36 receptor antagonist or IL-36Ra) that turns the alarm off once the threat is gone ^[1]^[2].

In GPP, this balance is lost. The “alarms” stay on or are triggered too easily, causing a self-amplifying loop of inflammation ^[3]. This leads to a massive recruitment of white blood cells (neutrophils) to the skin, which form the pustules that are the hallmark of the disease ^[3]^[4].

The Role of Genetics

For many patients, this biological “glitch” is rooted in their DNA. Several specific gene variants have been identified that make a person more susceptible to GPP:

IL36RN: This is the most common genetic link. This gene provides instructions for making the “silencer” (IL-36Ra). A pathogenic loss-of-function mutation in this gene means the body can’t produce enough of the silencer, leaving the inflammatory “alarm” running unchecked ^[5]. When this specific deficiency occurs, the condition is sometimes referred to as DITRA (Deficiency of IL-36 Receptor Antagonist) ^[5]. It often involves recessive inheritance, meaning a person must inherit two copies of the mutated gene.
CARD14 and AP1S3: These are other genes involved in skin inflammation. Gain-of-function mutations in CARD14 can cause the skin’s “alarm” system to be hyper-sensitive, while AP1S3 mutations interfere with how skin cells handle waste and signals, further fueling inflammation ^[6]^[7].

It is incredibly important to know that not every patient with GPP has these mutations. Depending on your background and the type of GPP you have, between 20% and 40% of patients might carry an IL36RN mutation, though this number can be much higher (up to 75% or more) in certain populations or in those who develop the disease as children ^[8]^[9]. Even if you have the mutation, you may still need an environmental “trigger”—like stress, infection, or pregnancy—to cause a flare ^[10]. Because inheritance and reproductive risks depend heavily on the specific variant and your family history, genetic counseling is highly recommended before and after testing.

Look-Alike Conditions

Because GPP is rare, it is frequently confused with other conditions. Distinguishing GPP from these “look-alikes” is a difficult process that usually requires a specialist evaluating your full medication history, clinical findings, cultures, and sometimes a skin biopsy.

Condition	How it differs from GPP
AGEP	Acute Generalized Exanthematous Pustulosis (AGEP) is usually a severe reaction to a specific drug (like an antibiotic) ^[11]. While AGEP often improves once the offending drug is stopped, it can be severe and can recur with re-exposure. Because GPP can also be triggered by a medication, distinguishing between a one-time AGEP reaction and the onset of lifelong GPP requires careful specialist assessment ^[11].
Plaque Psoriasis	While you can have both, typical plaque psoriasis involves thick, scaly patches. In GPP, the pustules appear on wide areas of bright red skin, often outside of any existing plaques ^[12].
Infections	Because the pustules are filled with white blood cells, they can look like a staph infection or “folliculitis.” GPP pustules are primarily driven by sterile inflammation, but broken skin can easily develop a secondary bacterial or fungal infection ^[12]. Doctors rely on appropriate microbiologic testing (cultures) to check for these secondary infections.

Your doctor may use a skin biopsy—taking a small sample of skin to look at under a microscope—to find supportive signs like “spongiform pustules of Kogoj,” which help evaluate the differential diagnosis of GPP ^[13]^[14]. Recognizing these differences ensures that you are treated for the correct underlying cause rather than just the symptoms on the surface.

Common questions in this guide

What causes generalized pustular psoriasis?

GPP is linked to an overactive IL-36 immune pathway, which can keep inflammation turned on and draw white blood cells into the skin to form pustules. Gene changes involving IL36RN, CARD14, or AP1S3 may increase susceptibility, although many people with GPP do not have one of these known variants.

Does an IL36RN mutation mean that I have GPP?

No. An IL36RN mutation can increase the likelihood of GPP or cause IL-36 receptor antagonist deficiency, but it does not by itself establish the diagnosis in every person. A genetic counselor and dermatologist can explain what a specific result means in light of your symptoms and family history.

How can doctors tell GPP apart from AGEP?

AGEP is usually a reaction to a medication and often improves after the responsible drug is stopped, while GPP may be a recurring inflammatory disease. Because medicines can also trigger GPP, specialists consider your medication history, symptom pattern, clinical findings, and disease course before deciding which condition is more likely.

Can GPP be mistaken for an infection or plaque psoriasis?

Yes. GPP pustules can resemble staph infection or folliculitis, and its red skin can differ from the thick, scaly plaques typical of plaque psoriasis. Cultures and a specialist examination help determine whether an infection is present and whether the overall pattern fits GPP.

What can a skin biopsy show in GPP?

A biopsy may show findings such as spongiform pustules of Kogoj or psoriasiform hyperplasia, which can support the evaluation of GPP. The biopsy is interpreted together with your symptoms, medication history, examination, and laboratory or culture results rather than used alone.

Curated prompts to bring to your next appointment.

1.Does my biopsy report show 'spongiform pustules of Kogoj' or 'psoriasiform hyperplasia', and how does that support the diagnosis?
2.Based on my symptoms and history, is a referral for genetic counseling and testing for IL36RN, CARD14, or AP1S3 mutations appropriate for me?
3.How do you differentiate my condition from AGEP, especially considering any medications I recently started?
4.Could a hidden infection, like a dental issue or a viral illness, be an underlying trigger for my flares?
5.If I have a genetic mutation, what does that mean for my family members, my future children, or my long-term prognosis?

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References (14)

1
The IL-36 cytokine family: From barrier immunity to therapeutic target in inflammatory diseases.
Satoh TK, Mellett M, French LE
Allergology international : official journal of the Japanese Society of Allergology 2026; (75(3)):366-379 doi:10.1016/j.alit.2026.01.006.
PMID: 41723100
2
Interleukin-36: Structure, Signaling and Function.
Zhou L, Todorovic V
Advances in experimental medicine and biology 2021; (21()):191-210 doi:10.1007/5584_2020_488.
PMID: 32026417
3
Mature IL-36γ Induces Stratum Corneum Exfoliation in Generalized Pustular Psoriasis by Suppressing Corneodesmosin.
Sato E, Imayoshi H, Tsutsui Y, et al.
The Journal of investigative dermatology 2024; (144(4)):764-773.e4 doi:10.1016/j.jid.2023.09.267.
PMID: 37827276
4
Pustular psoriasis: Molecular pathways and effects of spesolimab in generalized pustular psoriasis.
Baum P, Visvanathan S, Garcet S, et al.
The Journal of allergy and clinical immunology 2022; (149(4)):1402-1412 doi:10.1016/j.jaci.2021.09.035.
PMID: 34678325
5
IL36RN Mutations Affect Protein Expression and Function: A Basis for Genotype-Phenotype Correlation in Pustular Diseases.
Tauber M, Bal E, Pei XY, et al.
The Journal of investigative dermatology 2016; (136(9)):1811-1819 doi:10.1016/j.jid.2016.04.038.
PMID: 27220475
6
Activating CARD14 Mutations Are Associated with Generalized Pustular Psoriasis but Rarely Account for Familial Recurrence in Psoriasis Vulgaris.
Berki DM, Liu L, Choon SE, et al.
The Journal of investigative dermatology 2015; (135(12)):2964-2970 doi:10.1038/jid.2015.288.
PMID: 26203641
7
CARD14 alterations in Tunisian patients with psoriasis and further characterization in European cohorts.
Ammar M, Jordan CT, Cao L, et al.
The British journal of dermatology 2016; (174(2)):330-7 doi:10.1111/bjd.14158.
PMID: 26358359
8
Clinical profile of patients with acute generalized pustular psoriasis with and without IL36RN mutations in multi-ethnic Johor Bahru, Malaysia.
Choon SE, Tok PSK, Wong KW, et al.
Experimental dermatology 2023; (32(8)):1263-1271 doi:10.1111/exd.14776.
PMID: 36843152
9
Genetic polymorphism of IL36RN in Han patients with generalized pustular psoriasis in Sichuan region of China: A case-control study.
Li Z, Yang Q, Wang S
Medicine 2018; (97(31)):e11741 doi:10.1097/MD.0000000000011741.
PMID: 30075588
10
Toll-like receptor 4 antagonist TAK-242 inhibits autoinflammatory symptoms in DITRA.
Shibata A, Sugiura K, Furuta Y, et al.
Journal of autoimmunity 2017; (80()):28-38 doi:10.1016/j.jaut.2017.01.007.
PMID: 28196704
11
Clinical presentation and management of atypical and recalcitrant acute generalized exanthematous pustulosis.
Hadavand MA, Kaffenberger B, Cartron AM, Trinidad JCL
Journal of the American Academy of Dermatology 2022; (87(3)):632-639 doi:10.1016/j.jaad.2020.09.024.
PMID: 32926975
12
International Consensus Definition and Diagnostic Criteria for Generalized Pustular Psoriasis From the International Psoriasis Council.
Choon SE, van de Kerkhof P, Gudjonsson JE, et al.
JAMA dermatology 2024; (160(7)):758-768 doi:10.1001/jamadermatol.2024.0915.
PMID: 38691347
13
Case report: Successful treatment of acute generalized pustular psoriasis of puerperium with secukinumab.
Xue G, Lili M, Yimiao F, et al.
Frontiers in medicine 2022; (9()):1072039 doi:10.3389/fmed.2022.1072039.
PMID: 36569147
14
Acute Respiratory Distress Syndrome in a Carrier of an Interleukin-36 Receptor Antagonist Mutation With Generalized Pustular Psoriasis.
Baniel A, Bar-Ilan E, Hilerowicz Y, et al.
Journal of psoriasis and psoriatic arthritis 2022; (7(1)):9-12 doi:10.1177/24755303211051724.
PMID: 39296731

This page explains GPP biology and conditions that can resemble it for informational purposes only and does not replace medical advice. A dermatologist, pathologist, or genetic counselor should interpret your symptoms, biopsy, cultures, and genetic results.

Get notified when new evidence is published on Generalized pustular psoriasis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Guide Contents